Australia markets closed

Lumos Diagnostics Holdings Limited (LDX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0730-0.0030 (-3.95%)
At close: 04:10PM AEDT
Full screen
Previous close0.0760
Bid0.0730 x N/A
Ask0.0760 x N/A
Day's range0.0730 - 0.0750
52-week range0.0100 - 0.1750
Avg. volume7,071,811
Market cap35.135M
Beta (5Y monthly)0.77
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    Lumos Receives US FDA Clearance for FebriDx®

    Lumos Diagnostics (ASX: LDX), ("Lumos" or the "Company") a leader in rapid, point-of-care (POC) diagnostic technologies, is pleased to announce that it has received clearance from the US Food and Drug Administration (FDA) to market its FebriDx® rapid, point-of-care test in the United States.